Christopher A Lamb

Etrolizumab as induction therapy for ulcerative colitis: a randomised, controlled, phase 2 trial

Séverine Vermeire, Sharon O’Byrne, Mary Keir et al. · The Lancet · 2014 · 453 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +16

Infliximab is associated with attenuated immunogenicity to BNT162b2 and ChAdOx1 nCoV-19 SARS-CoV-2 vaccines in patients with IBD

Nicholas A. Kennedy, Simeng Lin, James Goodhand et al. · Gut · 2021 · 280 citations · Full text

Life Sciences, Immunology, Pharmacotherapy +17

British Society of Gastroenterology guidance for management of inflammatory bowel disease during the COVID-19 pandemic

Nicholas A. Kennedy, Gareth‐Rhys Jones, Christopher A Lamb et al. · Gut · 2020 · 256 citations · Full text

Medicine, Infectious Diseases, Internal Medicine +15

Human milk oligosaccharide DSLNT and gut microbiome in preterm infants predicts necrotising enterocolitis

A Masi, Nicholas D. Embleton, Christopher A Lamb et al. · Gut · 2020 · 224 citations · Full text

Life Sciences, Microbiology, Nutrition +17

Large-scale sequencing identifies multiple genes and rare variants associated with Crohn’s disease susceptibility

Aleksejs Sazonovs, Christine Stevens, Guhan Venkataraman et al. · Nature Genetics · 2022 · 189 citations · Full text

Life Sciences, Genetics, Molecular Genetics +17